Cryptococcal glucoxylomannan does not exhibit cross-reactivity in the MVista Histoplasma antigen enzyme immunoassay

David Zhuang, Chadi Hage, Magdia De Jesus, Emily Hackett, Michelle Durkin, Thomas Davis, Arturo Casadevall, L. Joseph Wheat

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The potential for cross-reaction between Cryptococcus neoformans and Histoplasma capsulatum in antigen assays was evaluated. We tested patient samples, spleens from infected mice, and purified polysaccharides in the MVista Histoplasma antigen enzyme immunoassay and cryptococcal antigen latex agglutination system for cross-reactivity, and none was observed.

Original languageEnglish
Pages (from-to)392-393
Number of pages2
JournalClinical and Vaccine Immunology
Volume15
Issue number2
DOIs
StatePublished - Feb 2008

Fingerprint

Histoplasma
Immunoenzyme Techniques
Antigens
Enzymes
Cryptococcus neoformans
Cross Reactions
Agglutination
Latex
Polysaccharides
Assays
Spleen

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Immunology
  • Immunology and Allergy
  • Microbiology (medical)
  • Medicine(all)

Cite this

Cryptococcal glucoxylomannan does not exhibit cross-reactivity in the MVista Histoplasma antigen enzyme immunoassay. / Zhuang, David; Hage, Chadi; Jesus, Magdia De; Hackett, Emily; Durkin, Michelle; Davis, Thomas; Casadevall, Arturo; Wheat, L. Joseph.

In: Clinical and Vaccine Immunology, Vol. 15, No. 2, 02.2008, p. 392-393.

Research output: Contribution to journalArticle

Zhuang, David ; Hage, Chadi ; Jesus, Magdia De ; Hackett, Emily ; Durkin, Michelle ; Davis, Thomas ; Casadevall, Arturo ; Wheat, L. Joseph. / Cryptococcal glucoxylomannan does not exhibit cross-reactivity in the MVista Histoplasma antigen enzyme immunoassay. In: Clinical and Vaccine Immunology. 2008 ; Vol. 15, No. 2. pp. 392-393.
@article{f11788e7e2434184a140fac1d8aa555e,
title = "Cryptococcal glucoxylomannan does not exhibit cross-reactivity in the MVista Histoplasma antigen enzyme immunoassay",
abstract = "The potential for cross-reaction between Cryptococcus neoformans and Histoplasma capsulatum in antigen assays was evaluated. We tested patient samples, spleens from infected mice, and purified polysaccharides in the MVista Histoplasma antigen enzyme immunoassay and cryptococcal antigen latex agglutination system for cross-reactivity, and none was observed.",
author = "David Zhuang and Chadi Hage and Jesus, {Magdia De} and Emily Hackett and Michelle Durkin and Thomas Davis and Arturo Casadevall and Wheat, {L. Joseph}",
year = "2008",
month = "2",
doi = "10.1128/CVI.00383-07",
language = "English",
volume = "15",
pages = "392--393",
journal = "Clinical and Vaccine Immunology",
issn = "1556-6811",
publisher = "American Society for Microbiology",
number = "2",

}

TY - JOUR

T1 - Cryptococcal glucoxylomannan does not exhibit cross-reactivity in the MVista Histoplasma antigen enzyme immunoassay

AU - Zhuang, David

AU - Hage, Chadi

AU - Jesus, Magdia De

AU - Hackett, Emily

AU - Durkin, Michelle

AU - Davis, Thomas

AU - Casadevall, Arturo

AU - Wheat, L. Joseph

PY - 2008/2

Y1 - 2008/2

N2 - The potential for cross-reaction between Cryptococcus neoformans and Histoplasma capsulatum in antigen assays was evaluated. We tested patient samples, spleens from infected mice, and purified polysaccharides in the MVista Histoplasma antigen enzyme immunoassay and cryptococcal antigen latex agglutination system for cross-reactivity, and none was observed.

AB - The potential for cross-reaction between Cryptococcus neoformans and Histoplasma capsulatum in antigen assays was evaluated. We tested patient samples, spleens from infected mice, and purified polysaccharides in the MVista Histoplasma antigen enzyme immunoassay and cryptococcal antigen latex agglutination system for cross-reactivity, and none was observed.

UR - http://www.scopus.com/inward/record.url?scp=40449117739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40449117739&partnerID=8YFLogxK

U2 - 10.1128/CVI.00383-07

DO - 10.1128/CVI.00383-07

M3 - Article

C2 - 18077616

AN - SCOPUS:40449117739

VL - 15

SP - 392

EP - 393

JO - Clinical and Vaccine Immunology

JF - Clinical and Vaccine Immunology

SN - 1556-6811

IS - 2

ER -